Trials / Sponsors / Cipherome, Inc.
Cipherome, Inc.
Industry · 7 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia Acute Lymphoblastic Leukemia, Pediatric, Adverse Drug Event | — | 2021-02-23 |
| Completed | DOAC ADRs Retrospective Study on Genetic Variations Drug-Related Side Effects and Adverse Reactions, Treatment Failure | — | 2021-02-01 |
| Completed | Evaluating Pharmacogenomic Variants for Cardiology Therapeutics Thrombosis, Stent Thrombosis, Bleeding | N/A | 2020-12-03 |
| Completed | Association Between Genetic Variant Scores and DOACs (DARES2) Drug-Related Side Effects and Adverse Reactions, Iatrogenic Disorder | — | 2020-10-07 |
| Completed | Association Between Genetic Variant Scores and P2Y12 Inhibitor Effects Stent Thrombosis, Ischemic Stroke, Myocardial Infarction | — | 2020-10-07 |
| Terminated | DOAC ADRs Retrospective Study Drug-Related Side Effects and Adverse Reactions | — | 2020-01-10 |
| Completed | Association Between Genetic Variant Scores and Warfarin Effect Atrial Fibrillation, Deep Vein Thrombosis, Intracardiac Thrombus | — | 2019-02-11 |